Drug Industry

For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best. Read full article >>

Sections:  news   business   
Topics:  drug industry   drugmaker   research   study   
RELATED ARTICLES
  • Study Finds Expanded Medicaid Increases Health Care Use
    Come January, millions of low-income adults will gain health insurance coverage through Medicaid in one of the farthest-reaching provisions of the Obama health care law. More
  • Bayer to pay $1.1B for California firm Conceptus
    Germany drug company Bayer AG says it intends to buy California-based Conceptus to expand its birth control offerings. Bayer said Monday it would launch a pupublicblic offer to pay $31.00 per share for all the stock in Conceptus, Inc. That means Bayer would pay $1.1 billion. More
  • New study: debt limit deadline likely extended
    The likely deadline for Congress to prevent the government's first default will be later than earlier thought, a Washington think tank has found. The Bipartisan Policy Center said Friday that the government probably won't reach the brink of default until early September or early October. More
  • Study: New bird flu jumped directly from chickens
    Chinese scientists have for the first time found strong evidence of how humans got infected with a new strain of bird flu: from chickens at a live market. In a small study of four patients who caught the new H7N9 virus, Chinese scientists compared swabs from birds at live markets in eastern China to virus samples from patients. More
  • Hospitals Profit From Surgical Errors, Study Finds
    Since insurers pay more for patients with surgical complications, some hospitals could actually lose money by improving care, researchers said Tuesday. More
BING NEWS:
  • Doctors received approximately $12.1 billion from drug and device makers between 2013–2022, study reveals
    Despite evidence that financial conflicts of interest may influence medical practice and research and may erode patient trust in medical professionals, these relationships remain pervasive. According ...
    03/28/2024 - 5:08 am | View Link
  • Global Complementary and Alternative Medicine for Anti Aging & Longevity Industry is expected to generate US$347.7 Billion in revenue By 2032 | FMI
    The Global Complementary and Alternative Medicine for Anti-Aging and Longevity Industry, estimated at $44.6 billion in 2021, is expected to increase at a CAGR of 24.4% from 2022 to 2032. As the world ...
    03/26/2024 - 12:55 am | View Link
  • Global Cloud-Based Drug Discovery Platform Industry is expected to grow at a 12.6% CAGR and be valued US$ 7,529.59 Million By 2032 | FMI
    The Global Cloud-Based Drug Discovery Platform Industry is expected to develop at a CAGR of 12.6% over the forecast period. In 2022, the market is already causing waves, with an anticipated value of ...
    03/22/2024 - 2:58 am | View Link
  • Research reveals new starting points for the rapid and targeted development of future drugs
    Many important medicines, such as antibiotics and anticancer drugs, are derived from natural products of bacteria. The enzyme complexes that produce these active ingredients have a modular design that ...
    03/21/2024 - 9:15 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News